CLINICAL RESEARCH: CARDIOMYOPATHY
The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms
Camillo Autore, MD*,*,
Paola Bernabò, MD ,
Caterina Stella Barillà, MD*,
Paolo Bruzzi, MD, PhD and
Paolo Spirito, MD
* Divisione di Cardiologia, Ospedale Sant'Andrea, Università "La Sapienza", Rome
Divisione di Cardiologia, Ente Ospedali Galliera, Genoa
Servizio di Epidemiologia Clinica, Istituto Nazionale Ricerca sul Cancro, Genoa, Italy
Manuscript received May 28, 2004;
revised manuscript received November 2, 2004,
accepted December 21, 2004.
* Reprint requests and correspondence: Dr. Camillo Autore, Università di Roma "La Sapienza", Ospedale Sant'Andrea, Via Grottarossa 1035–1039; 00189 Rome, Italy
(Email: camillo.autore{at}uniroma1.it).
OBJECTIVES: The aim of this study was to investigate whether the prognostic importance of left ventricular (LV) outflow obstruction in hypertrophic cardiomyopathy (HCM) is influenced by other predictors of morbidity and mortality.
BACKGROUND: It remains unknown whether the effect of outflow obstruction on clinical outcome in HCM is influenced by other determinants of survival.
METHODS: We assessed the impact of severity of symptoms, LV wall thickness, atrial fibrillation, and age on the prognostic importance of outflow obstruction in a large HCM population.
RESULTS: Of 526 consecutive HCM patients, 141 (27%) had outflow obstruction. During a follow-up of 4.5 ± 4.1 years, 34 patients died of HCM. The incidence of cardiovascular death was significantly higher among patients with LV obstruction than among those without obstruction (relative risk [RR] = 2.14; p = 0.02). The prognostic power of the outflow gradient changed in relation to severity of symptoms (p = 0.024). At initial evaluation, LV obstruction was a significant predictor of cardiovascular mortality only in New York Heart Association (NYHA) functional class I to II patients (hazard ratio [HR] = 2.38; p = 0.025). During follow-up, at time of development of severe symptoms, the outflow gradient lost its prognostic significance (HR = 1.18; p = 0.66), whereas NYHA functional class III to IV was associated with an eight-fold increase in risk of cardiovascular mortality (HR = 7.90; p < 0.001).
CONCLUSIONS: In patients with HCM, the prognostic importance of LV outflow obstruction varies in relation to the severity of symptoms. In patients with mild or no symptoms, obstruction is an important predictor of cardiovascular death. After development of severe symptoms, NYHA functional class becomes the dominant marker of prognosis independently of the presence of an outflow gradient.
|
Abbreviations and Acronyms
| | AF = atrial fibrillation | | CI = confidence interval | | HCM = hypertrophic cardiomyopathy | | HR = hazard ratio | | LV = left ventricular | | NYHA = New York Heart Association |
|
This article has been cited by other articles:
|
|
|
|
 
M. F. Eleid, T. Konecny, M. Orban, P. P. Sengupta, V. K. Somers, J. M. Parish, F. Mookadam, P. A. Brady, B. L. Sullivan, B. K. Khandheria, et al.
High prevalence of abnormal nocturnal oximetry in patients with hypertrophic cardiomyopathy.
J. Am. Coll. Cardiol.,
November 3, 2009;
54(19):
1805 - 1809.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Sorajja, R. A. Nishimura, B. J. Gersh, J. A. Dearani, D. O. Hodge, H. J. Wiste, and S. R. Ommen
Outcome of mildly symptomatic or asymptomatic obstructive hypertrophic cardiomyopathy: a long-term follow-up study.
J. Am. Coll. Cardiol.,
July 14, 2009;
54(3):
234 - 241.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Spirito, C. Autore, C. Rapezzi, P. Bernabo, R. Badagliacca, M. S. Maron, S. Bongioanni, F. Coccolo, N.A. M. Estes, C. S. Barilla, et al.
Syncope and Risk of Sudden Death in Hypertrophic Cardiomyopathy
Circulation,
April 7, 2009;
119(13):
1703 - 1710.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Rudolph, H. Abdel-Aty, S. Bohl, P. Boye, A. Zagrosek, R. Dietz, and J. Schulz-Menger
Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling.
J. Am. Coll. Cardiol.,
January 20, 2009;
53(3):
284 - 291.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. T Murphy
Bringing the obstruction back into hypertrophic cardiomyopathy
Heart,
October 1, 2008;
94(10):
1249 - 1250.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D H Kwon, R M Setser, M Thamilarasan, Z V Popovic, N G Smedira, P Schoenhagen, M J Garcia, H M Lever, and M Y Desai
Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy
Heart,
October 1, 2008;
94(10):
1295 - 1301.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J S Shah, M T T Esteban, R Thaman, R Sharma, B Mist, A Pantazis, D Ward, S K Kohli, S P Page, C Demetrescu, et al.
Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy
Heart,
October 1, 2008;
94(10):
1288 - 1294.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P Steendijk, E Meliga, M Valgimigli, F J Ten Cate, and P W Serruys
Acute effects of alcohol septal ablation on systolic and diastolic left ventricular function in patients with hypertrophic obstructive cardiomyopathy
Heart,
October 1, 2008;
94(10):
1318 - 1322.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. S. Maron, E. Appelbaum, C. J. Harrigan, J. Buros, C. M. Gibson, C. Hanna, J. R. Lesser, J. E. Udelson, W. J. Manning, and B. J. Maron
Clinical Profile and Significance of Delayed Enhancement in Hypertrophic Cardiomyopathy
Circ Heart Fail,
September 1, 2008;
1(3):
184 - 191.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Olivotto, M. S. Maron, C. Autore, J. R. Lesser, L. Rega, G. Casolo, M. De Santis, G. Quarta, S. Nistri, F. Cecchi, et al.
Assessment and Significance of Left Ventricular Mass by Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy
J. Am. Coll. Cardiol.,
August 12, 2008;
52(7):
559 - 566.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. S. Maron, I. Olivotto, A. G. Zenovich, M. S. Link, N. G. Pandian, J. T. Kuvin, S. Nistri, F. Cecchi, J. E. Udelson, and B. J. Maron
Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction
Circulation,
November 21, 2006;
114(21):
2232 - 2239.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. M. Elliott, J. R. Gimeno, M. T. Tome, J. Shah, D. Ward, R. Thaman, J. Mogensen, and W. J. McKenna
Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy
Eur. Heart J.,
August 2, 2006;
27(16):
1933 - 1941.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Spirito and C. Autore
Management of hypertrophic cardiomyopathy.
BMJ,
May 27, 2006;
332(7552):
1251 - 1255.
[Full Text]
[PDF]
|
|
|
|
